Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung Cancer.

Wang, Fang; Guo, Gui-Fang; Qiu, Hui-Juan; He, Wen-Zhuo; Zhou, Fei-Fei; Chen, Xu-Xian; Hu, Pi-Li; Zhang, Bei; Yin, Chen-Xi; Zhang, Li; Xia, Liang-Ping

Wang, Fang; Guo, Gui-Fang; Qiu, Hui-Juan; He, Wen-Zhuo; Zhou, Fei-Fei; Chen, Xu-Xian; Hu, Pi-Li; Zhang, Bei; Yin, Chen-Xi; Zhang, Li; Xia, Liang-Ping.

Afiliación

Wang F; State Key Laboratory of Oncology in South China, Guangzhou 510060, China ; VIP Region, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

Cancer Biol Med ; 9(1): 38-43, 2012 Mar.

Article en En | MEDLINE | ID: mdl-23691453

Palabras clave

chemotherapy; erlotinib; lung neoplasm; survival analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Biol Med Año: 2012 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google